BioPharmSignal logoBioPharmSignal

Biotech News

RxSight, Inc. to Present at the Stifel 2026 Virtual Ophthalmology Forum

RxSight (RXST)RxSightCompany update

ALISO VIEJO, Calif., May 19, 2026 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) RxSight, Inc., today announced plans to participate in the upcoming Stifel 2026 Virtual Ophthalmology Forum. Management is scheduled to participate in a fireside chat on Tuesday, May 26, 2026, at 10:00 a.m. Pacific Time.

Open original release

Related news

RXSTRxSight2026-04-29 20:10 EST

RxSight, Inc. to Present at the Bank of America Healthcare Conference

RXSTRxSight2026-04-02 20:10 EST

RxSight, Inc. to Participate in the 25th Annual Needham Virtual Healthcare Conference

PLSEPulse Biosciences2026-04-02 20:05 EST

Pulse Biosciences to Present at the 25th Annual Needham Virtual Healthcare Conference

ANGOAngioDynamics2026-03-31 12:00 EST

AngioDynamics to Present at the 25th Annual Needham Virtual Healthcare Conference

IARTIntegra LifeSciences2026-06-02 11:30 EST

Integra LifeSciences to Present at the 2026 Jefferies Global Healthcare Conference

CVRXCVRx2026-05-27 20:30 EST

CVRx to Present at the Goldman Sachs 47th Annual Global Healthcare Conference

PLSEPulse Biosciences2026-05-27 20:05 EST

Pulse Biosciences to Present at the Goldman Sachs 47th Annual Global Healthcare Conference 2026

CVRXCVRx2026-05-20 20:30 EST

CVRx to Present at the William Blair 46th Annual Growth Stock Conference

TCMDTactile Systems Technology, Inc.2026-05-20 20:05 EST

Tactile Medical to Present at the William Blair 46th Annual Growth Stock Conference

IARTIntegra LifeSciences2026-05-08 12:00 EST

Integra LifeSciences to Present at the BofA Securities 2026 Health Care Conference

View all latest news

RxSight

RxSight is a medical device company focused on adjustable intraocular lenses for cataract surgery. Its business is built around ophthalmic procedure adoption and premium eye-care technology.

Recent company news

RXSTRxSight2026-05-19 20:10 EST

RxSight, Inc. to Present at the Stifel 2026 Virtual Ophthalmology Forum

RXSTRxSight2026-05-06 20:05 EST

RxSight, Inc. Reports First Quarter 2026 Results and Reiterates Full-Year Sales Outlook

RXSTRxSight2026-04-29 20:10 EST

RxSight, Inc. to Present at the Bank of America Healthcare Conference

RXSTRxSight2026-04-22 20:10 EST

RxSight, Inc. to Report First Quarter 2026 Financial Results on May 6

RXSTRxSight2026-04-08 20:05 EST

RxSight Highlights 300,000 Light Adjustable Lens Implant Milestone and Strong Scientific Presence at ASCRS 2026

Stock data

Close
5.64 USD
Market cap
204.5M USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States